Vagus Nerve Stimulation Market Size, Share, Trends & Growth Analysis

Global Vagus Nerve Stimulation Market Size, Share, Trends, Industry Growth by Product (Implantable, External), by Biomaterial (Metallic, Ceramics, Polymeric), by application, by End-Use, by Region, and Forecast to 2030

Report ID: RC81169 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: June 30th, 2023

The global vagus nerve stimulation market size is anticipated to register a considerable CAGR of over 10% during the forecast period from 2023 to 2030. The rising prevalence of anxiety and epilepsy disorders coupled with the growing geriatric population around the world are some major factors driving the industry. Furthermore, the Introduction of technologically advanced products and the growing prevalence of chronic disorders such as migraine are further anticipated to fuel the market over the forecast period. Moreover, the increasing research & development for effective and advanced vagus nerve stimulators is projected to propel the industry growth in the next upcoming years.

Market Drivers:

Increasing Prevalence of Neurological Disorders: Neurological disorders, such as epilepsy, depression, and migraine, are becoming more prevalent globally. Vagus nerve stimulation has emerged as a therapeutic option for these conditions. The rising incidence and diagnosis of neurological disorders have contributed to the increased adoption of VNS, driving market growth.

Effectiveness in Treating Epilepsy: Vagus nerve stimulation has been proven to be effective in reducing the frequency and severity of seizures in patients with epilepsy. As a result, VNS has gained acceptance as an adjunctive treatment for drug-resistant epilepsy, where medications alone are insufficient. The effectiveness of VNS in managing epilepsy has been a significant driver for its adoption and market growth.

Growing Demand for Alternative and Adjunctive Therapies: There is a growing demand for alternative and adjunctive therapies for neurological and psychiatric conditions. Vagus nerve stimulation offers a non-pharmacological treatment option that can be used in combination with medication or when medications are ineffective. This demand for alternative treatment approaches has fueled the adoption of VNS, driving the market growth.

Advancements in Vagus Nerve Stimulation Devices: The development of advanced VNS devices has played a crucial role in the growth of the market. Modern VNS devices are more compact, customizable, and user-friendly, improving patient comfort and ease of use. Furthermore, advancements in device programming and control have enhanced the efficacy and safety of VNS therapy, encouraging its adoption and market expansion.

Favorable Reimbursement Policies: Reimbursement policies and coverage for VNS therapy have improved in many countries, making it more accessible and affordable for patients. The availability of reimbursement support has encouraged healthcare providers to adopt VNS as a treatment option and has driven market growth.

Research and Development Efforts: Ongoing research and development activities focused on VNS therapy have contributed to market growth. Clinical studies exploring the applications of VNS in various neurological and psychiatric conditions have provided evidence of its efficacy and safety. Additionally, research efforts aimed at developing innovative stimulation techniques and optimizing device parameters have expanded the possibilities and potential applications of VNS, driving market growth.

Market Snapshot:

Benchmark Year		2022
Market Size		$ xx.x Mn
Market Growth (CAGR)		> 10%
Largest Market Share		North America
Analysis Period		2020-2030
Market Players		Medtronic, LivaNova PLC, electroCore, Inc., Cirtec, and Brain Control Co. Limited

Market Insights:

By product type, the implantable device segment dominated the global vagus nerve stimulation market in the benchmark year

The global vagus nerve stimulation market is bifurcated into product type, biomaterial, application, end-use, and geography. On the basis of product type, the market is further segmented into implantable and external VNS devices. The implantable device segment is expected to hold the largest revenue share of around 60% market share by the end of the analysis period. The increasing incidence of epilepsy and anxiety disorders among people is one of the prominent factor driving the segment growth. On the flip side, the external devices segment is accounted to register the fastest growth rate over the forecast period. The increasing demand for non-invasive procedures and the growing prevalence of chronic disorders are expected to fuel the segment’s growth over the forecast period.

By application, the depression segment is expected to register the fastest CAGR over the forecast period

On the basis of application, the market is segmented into epilepsy, depression, and migraine. The epilepsy segment dominated the global vagus nerve stimulation market in 2022 and expected to hold the largest revenue share of over half of the market by the end of the analysis period. The high prevalence rate of epilepsy is one of the key factor driving the segment growth. On the flip side, the depression segment is anticipated to grow at the fastest growth rate over the forecast period. The increasing incidence of stress and depression coupled with the growing geriatric population around the world is expected to fuel the segment growth over the forecast period.

Vagus Nerve Stimulation Market Growth

To know more about the research study, request sample papers

The vagus nerve stimulation comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2023 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The vagus nerve stimulation market research report presents the analysis of each segment from 2020 to 2030 considering 2022 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2023 to 2030.

Historical & Forecast Period

2020-21 – Historical Year
2022 – Base Year
2023-2030 – Forecast Period

Market Segmentation:

By Product:

Implantable
External

By Biomaterial:

Metallic
Ceramics
Polymeric

By Application:

Epilepsy
Depression
Migraine

By End-Use:

Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Regional Analysis:

By region, North America is accounted to dominate the global market in 2022

Geographically, North America dominated the global vagus nerve stimulation market in 2022 and anticipated to maintain its dominance over the forecast period. The increasing investment by the government in the awareness program for epilepsy disorder is a significant factor driving the market growth in the region. Furthermore, technological advancement, the growing incidence of depression, and the presence of major market players are anticipated to fuel market growth in North America. On the other hand, the Asia Pacific is estimated to grow at the fastest CAGR owing to the growing prevalence of neurodegenerative disorders.

The vagus nerve stimulation market report comprises dedicated sections centering on the regional market revenue and trends. The vagus nerve stimulation market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The vagus nerve stimulation market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Vagus nerve stimulation market estimates have also been provided for the historical years 2020 & 2021 along with forecasts for the period from 2023 – 2030.

Competitive Assessment:

Some of the major market players operating in the global vagus nerve stimulation market are Medtronic, LivaNova PLC, electroCore, Inc., Cirtec, and Brain Control Co. Limited. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Medtronic
LivaNova PLC
electroCore, Inc.
Cirtec
Brain Control Co. Limited
Soterix Medical Inc.
SetPoint Medical
MicroTransponder Inc.
Parasym Ltd.
tVNS Technologies GmbH

Key Questions Answered by Vagus Nerve Stimulation Market Report

Global vagus nerve stimulation market forecasts from 2023-2030
Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
Vagus nerve stimulation submarket forecasts from 2023-2030 covering the market by product, biomaterial, application, end-use, and geography
Various industry models such as SWOT analysis, Value Chain Analysis about the market
Analysis of the key factors driving and restraining the growth of the global, regional, and country-level vagus nerve stimulation markets from 2023-2030
Competitive Landscape and market positioning of the top 10 players operating in the market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Vagus Nerve Stimulation Market Portraiture
2.2. Global Vagus Nerve Stimulation Market, by Product, 2022 (USD Mn)
2.3. Global Vagus Nerve Stimulation Market, by Biomaterial, 2022 (USD Mn)
2.4. Global Vagus Nerve Stimulation Market, by Application, 2022 (USD Mn)
2.5. Global Vagus Nerve Stimulation Market, by End-Use, 2022 (USD Mn)
2.6. Global Vagus Nerve Stimulation Market, by Geography, 2022 (USD Mn)

3. Global Vagus Nerve Stimulation Market Analysis

3.1. Vagus Nerve Stimulation Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis

4. Global Vagus Nerve Stimulation Market By Product, 2020 – 2030 (USD Mn)

4.1. Overview
4.2. Implantable
4.3. External

5. Global Vagus Nerve Stimulation Market By Biomaterial, 2020 – 2030 (USD Mn)

5.1. Overview
5.2. Metallic
5.3. Ceramics
5.4. Polymeric

6. Global Vagus Nerve Stimulation Market By Application, 2020 – 2030 (USD Mn)

6.1. Overview
6.2. Epilepsy
6.3. Depression
6.4. Migraine

7. Global Vagus Nerve Stimulation Market By End-Use, 2020 – 2030 (USD Mn)

7.1. Overview
7.2. Hospitals
7.3. Neurology Clinics
7.4. Ambulatory Surgical Centers
7.5. Research Centers

8. North America Vagus Nerve Stimulation Market Analysis and Forecast, 2020 – 2030 (USD Mn)

8.1. Overview
8.2. North America Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
8.3. North America Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
8.4. North America Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
8.5. North America Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
8.6. North America Vagus Nerve Stimulation Market by Country, (2020-2030 USD Mn)
8.6.1. U.S.
8.6.1.1. U.S. Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
8.6.1.2. U.S. Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
8.6.1.3. U.S. Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
8.6.1.4. U.S. Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
8.6.2. Canada
8.6.2.1. Canada Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
8.6.2.2. Canada Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
8.6.2.3. Canada Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
8.6.2.4. Canada Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)

9. Europe Vagus Nerve Stimulation Market Analysis and Forecast, 2020 - 2030 (USD Mn)

9.1. Overview
9.2. Europe Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.3. Europe Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.4. Europe Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.5. Europe Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
9.6. Europe Vagus Nerve Stimulation Market by Country, (2020-2030 USD Mn)
9.6.1. Germany
9.6.1.1. Germany Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.6.1.2. Germany Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.6.1.3. Germany Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.6.1.4. Germany Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
9.6.2. U.K.
9.6.2.1. U.K. Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.6.2.2. U.K. Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.6.2.3. U.K. Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.6.2.4. U.K. Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
9.6.3. France
9.6.3.1. France Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.6.3.2. France Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.6.3.3. France Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.6.3.4. France Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
9.6.4. Spain
9.6.4.1. Spain Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.6.4.2. Spain Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.6.4.3. Spain Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.6.4.4. Spain Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
9.6.5. Italy
9.6.5.1. Italy Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.6.5.2. Italy Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.6.5.3. Italy Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.6.5.4. Italy Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
9.6.6. Rest of Europe
9.6.6.1. Rest of Europe Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
9.6.6.2. Rest of Europe Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
9.6.6.3. Rest of Europe Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
9.6.6.4. Rest of Europe Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)

10. Asia Pacific Vagus Nerve Stimulation Market Analysis and Forecast, 2020 - 2030 (USD Mn)

10.1. Overview
10.2. Asia Pacific Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
10.3. Asia Pacific Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
10.4. Asia Pacific Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
10.5. Asia Pacific Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
10.6. Asia Pacific Vagus Nerve Stimulation Market by Country, (2020-2030 USD Mn)
10.6.1. China
10.6.1.1. China Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
10.6.1.2. China Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
10.6.1.3. China Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
10.6.1.4. China Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
10.6.2. Japan
10.6.2.1. Japan Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
10.6.2.2. Japan Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
10.6.2.3. Japan Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
10.6.2.4. Japan Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
10.6.3. India
10.6.3.1. India Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
10.6.3.2. India Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
10.6.3.3. India Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
10.6.3.4. India Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
10.6.4. Rest of Asia Pacific
10.6.4.1. Rest of Asia Pacific Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
10.6.4.2. Rest of Asia Pacific Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
10.6.4.3. Rest of Asia Pacific Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
10.6.4.4. Rest of Asia Pacific Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)

11. Latin America (LATAM) Vagus Nerve Stimulation Market Analysis and Forecast, 2020 - 2030 (USD Mn)

11.1. Overview
11.2. Latin America Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
11.3. Latin America Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
11.4. Latin America Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
11.5. Latin America Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
11.6. Latin America Vagus Nerve Stimulation Market by Country, (2020-2030 USD Mn)
11.6.1. Brazil
11.6.1.1. Brazil Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
11.6.1.2. Brazil Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
11.6.1.3. Brazil Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
11.6.1.4. Brazil Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
11.6.2. Mexico
11.6.2.1. Mexico Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
11.6.2.2. Mexico Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
11.6.2.3. Mexico Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
11.6.2.4. Mexico Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
11.6.3.2. Rest of Latin America Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
11.6.3.3. Rest of Latin America Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
11.6.3.4. Rest of Latin America Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)

12. Middle East and Africa Vagus Nerve Stimulation Market Analysis and Forecast, 2020 - 2030 (USD Mn)

12.1. Overview
12.2. MEA Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
12.3. MEA Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
12.4. MEA Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
12.5. MEA Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
12.6. Middle East and Africa Vagus Nerve Stimulation Market, by Country, (2020-2030 USD Mn)
12.6.1. GCC
12.6.1.1. GCC Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
12.6.1.2. GCC Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
12.6.1.3. GCC Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
12.6.1.4. GCC Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
12.6.2. South Africa
12.6.2.1. South Africa Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
12.6.2.2. South Africa Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
12.6.2.3. South Africa Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
12.6.2.4. South Africa Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Vagus Nerve Stimulation Market by Product, (2020-2030 USD Mn)
12.6.3.2. Rest of MEA Vagus Nerve Stimulation Market by Biomaterial, (2020-2030 USD Mn)
12.6.3.3. Rest of MEA Vagus Nerve Stimulation Market by Application, (2020-2030 USD Mn)
12.6.3.4. Rest of MEA Vagus Nerve Stimulation Market by End-Use, (2020-2030 USD Mn)

13. Company Profiles

13.1. Medtronic
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. LivaNova PLC
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. electroCore, Inc.
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Cirtec
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. Brain Control Co. Limited
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Soterix Medical Inc.
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. SetPoint Medical
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. MicroTransponder Inc.
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Parasym Ltd.
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. tVNS Technologies GmbH
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis

Fill the given form to inquiry before buying for Global Vagus Nerve Stimulation Market Size, Share, Trends, Industry Growth by Product (Implantable, External), by Biomaterial (Metallic, Ceramics, Polymeric), by application, by End-Use, by Region, and Forecast to 2030 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$ 6995/- Corporate License

For Any Assitance

Email: sales@researchcorridor.com